BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Siliņa K, Rulle U, Kalniņa Z, Linē A. Manipulation of tumour-infiltrating B cells and tertiary lymphoid structures: a novel anti-cancer treatment avenue? Cancer Immunol Immunother 2014;63:643-62. [DOI: 10.1007/s00262-014-1544-9] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Guo FF, Cui JW. The Role of Tumor-Infiltrating B Cells in Tumor Immunity. J Oncol 2019;2019:2592419. [PMID: 31662750 DOI: 10.1155/2019/2592419] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
2 Tang S, Huang X, Jiang H, Qin S. Identification of a Five-Gene Prognostic Signature Related to B Cells Infiltration in Pancreatic Adenocarcinoma. Int J Gen Med 2021;14:5051-68. [PMID: 34511988 DOI: 10.2147/IJGM.S324432] [Reference Citation Analysis]
3 Benhamou Y, Picco V, Raybaud H, Sudaka A, Chamorey E, Brolih S, Monteverde M, Merlano M, Lo Nigro C, Ambrosetti D, Pagès G. Telomeric repeat-binding factor 2: a marker for survival and anti-EGFR efficacy in oral carcinoma. Oncotarget 2016;7:44236-51. [PMID: 27329590 DOI: 10.18632/oncotarget.10005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
4 Soo RA, Chen Z, Yan Teng RS, Tan HL, Iacopetta B, Tai BC, Soong R. Prognostic significance of immune cells in non-small cell lung cancer: meta-analysis. Oncotarget 2018;9:24801-20. [PMID: 29872507 DOI: 10.18632/oncotarget.24835] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 8.3] [Reference Citation Analysis]
5 Pang Z, Chen X, Wang Y, Wang Y, Yan T, Wan J, Wang K, Du J. Long non-coding RNA C5orf64 is a potential indicator for tumor microenvironment and mutation pattern remodeling in lung adenocarcinoma. Genomics 2021;113:291-304. [PMID: 33309768 DOI: 10.1016/j.ygeno.2020.12.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
6 Liu M, Sun Q, Wang J, Wei F, Yang L, Ren X. A new perspective: Exploring future therapeutic strategies for cancer by understanding the dual role of B lymphocytes in tumor immunity. Int J Cancer. 2019;144:2909-2917. [PMID: 30183084 DOI: 10.1002/ijc.31850] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
7 Teillaud JL, Dieu-Nosjean MC. Tertiary Lymphoid Structures: An Anti-tumor School for Adaptive Immune Cells and an Antibody Factory to Fight Cancer? Front Immunol 2017;8:830. [PMID: 28785261 DOI: 10.3389/fimmu.2017.00830] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 6.2] [Reference Citation Analysis]
8 Guy TV, Terry AM, Bolton HA, Hancock DG, Shklovskaya E, Fazekas de St. Groth B. Pro- and anti-tumour effects of B cells and antibodies in cancer: a comparison of clinical studies and preclinical models. Cancer Immunol Immunother 2016;65:885-96. [PMID: 27222052 DOI: 10.1007/s00262-016-1848-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
9 Qin M, Jin Y, Pan LY. Tertiary lymphoid structure and B-cell-related pathways: A potential target in tumor immunotherapy. Oncol Lett 2021;22:836. [PMID: 34712360 DOI: 10.3892/ol.2021.13097] [Reference Citation Analysis]
10 Silina K, Kroeger D. Editorial: Immune Outposts on the Inflammatory Frontier: Tertiary Lymphoid Structures as Targets for Immunotherapy of Cancer and Autoimmunity. Front Immunol 2019;10:993. [PMID: 31130966 DOI: 10.3389/fimmu.2019.00993] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Wu J, Li X, Song W, Fang Y, Yu L, Liu S, Churilov LP, Zhang F. The roles and applications of autoantibodies in progression, diagnosis, treatment and prognosis of human malignant tumours. Autoimmun Rev. 2017;16:1270-1281. [PMID: 29042252 DOI: 10.1016/j.autrev.2017.10.012] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 6.8] [Reference Citation Analysis]
12 Song P, Li W, Wu X, Qian Z, Ying J, Gao S, He J. Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on B cell marker genes to predict prognosis and immunotherapy response in lung adenocarcinoma. Cancer Immunol Immunother 2022. [PMID: 35152302 DOI: 10.1007/s00262-022-03143-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Siliņa K, Burkhardt C, Casanova R, Solterman A, van den Broek M. A Quantitative Pathology Approach to Analyze the Development of Human Cancer-Associated Tertiary Lymphoid Structures. In: Dieu-nosjean M, editor. Tertiary Lymphoid Structures. New York: Springer; 2018. pp. 71-86. [DOI: 10.1007/978-1-4939-8709-2_5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
14 Chiaruttini G, Mele S, Opzoomer J, Crescioli S, Ilieva KM, Lacy KE, Karagiannis SN. B cells and the humoral response in melanoma: The overlooked players of the tumor microenvironment. Oncoimmunology 2017;6:e1294296. [PMID: 28507802 DOI: 10.1080/2162402X.2017.1294296] [Cited by in Crossref: 34] [Cited by in F6Publishing: 20] [Article Influence: 6.8] [Reference Citation Analysis]
15 Schumacher TN, Thommen DS. Tertiary lymphoid structures in cancer. Science 2022;375:eabf9419. [PMID: 34990248 DOI: 10.1126/science.abf9419] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 16.0] [Reference Citation Analysis]
16 Buisseret L, Garaud S, de Wind A, Van den Eynden G, Boisson A, Solinas C, Gu-Trantien C, Naveaux C, Lodewyckx JN, Duvillier H, Craciun L, Veys I, Larsimont D, Piccart-Gebhart M, Stagg J, Sotiriou C, Willard-Gallo K. Tumor-infiltrating lymphocyte composition, organization and PD-1/ PD-L1 expression are linked in breast cancer. Oncoimmunology 2017;6:e1257452. [PMID: 28197375 DOI: 10.1080/2162402X.2016.1257452] [Cited by in Crossref: 77] [Cited by in F6Publishing: 60] [Article Influence: 12.8] [Reference Citation Analysis]
17 Khoa Ta HD, Tang WC, Phan NN, Anuraga G, Hou SY, Chiao CC, Liu YH, Wu YF, Lee KH, Wang CY. Analysis of LAGEs Family Gene Signature and Prognostic Relevance in Breast Cancer. Diagnostics (Basel) 2021;11:726. [PMID: 33921749 DOI: 10.3390/diagnostics11040726] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
18 Chen XY, Yeong J, Thike AA, Bay BH, Tan PH. Prognostic role of immune infiltrates in breast ductal carcinoma in situ. Breast Cancer Res Treat 2019;177:17-27. [PMID: 31134489 DOI: 10.1007/s10549-019-05272-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
19 Seiller C, Dubois B. [Infiltrated B cells promote pancreatic ductal adenocarcinoma]. Med Sci (Paris) 2017;33:859-62. [PMID: 28994380 DOI: 10.1051/medsci/20173310015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
20 Allard B, Aspeslagh S, Garaud S, Dupont FA, Solinas C, Kok M, Routy B, Sotiriou C, Stagg J, Buisseret L. Immuno-oncology-101: overview of major concepts and translational perspectives. Semin Cancer Biol 2018;52:1-11. [PMID: 29428479 DOI: 10.1016/j.semcancer.2018.02.005] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
21 Devi-Marulkar P, Kaplon H, Dieu-Nosjean MC, Lawand M. Designed Methods for the Sorting of Tertiary Lymphoid Structure-Immune Cell Populations. Methods Mol Biol 2018;1845:189-204. [PMID: 30141014 DOI: 10.1007/978-1-4939-8709-2_11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Koti M, Xu AS, Ren KYM, Visram K, Ren R, Berman DM, Siemens DR. Tertiary Lymphoid Structures Associate with Tumour Stage in Urothelial Bladder Cancer. Bladder Cancer 2017;3:259-67. [PMID: 29152550 DOI: 10.3233/BLC-170120] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
23 Solinas C, Pusole G, Demurtas L, Puzzoni M, Mascia R, Morgan G, Giampieri R, Scartozzi M. Tumor infiltrating lymphocytes in gastrointestinal tumors: Controversies and future clinical implications. Crit Rev Oncol Hematol 2017;110:106-16. [PMID: 28109400 DOI: 10.1016/j.critrevonc.2016.11.016] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
24 Sharonov GV, Serebrovskaya EO, Yuzhakova DV, Britanova OV, Chudakov DM. B cells, plasma cells and antibody repertoires in the tumour microenvironment. Nat Rev Immunol 2020;20:294-307. [DOI: 10.1038/s41577-019-0257-x] [Cited by in Crossref: 86] [Cited by in F6Publishing: 85] [Article Influence: 43.0] [Reference Citation Analysis]
25 Pagliarulo F, Cheng PF, Brugger L, van Dijk N, van den Heijden M, Levesque MP, Silina K, van den Broek M. Molecular, Immunological, and Clinical Features Associated With Lymphoid Neogenesis in Muscle Invasive Bladder Cancer. Front Immunol 2022;12:793992. [DOI: 10.3389/fimmu.2021.793992] [Reference Citation Analysis]
26 Pang Z, Chen X, Wang Y, Wang Y, Yan T, Wan J, Du J. Comprehensive analyses of the heterogeneity and prognostic significance of tumor-infiltrating immune cells in non-small-cell lung cancer: Development and validation of an individualized prognostic model. Int Immunopharmacol 2020;86:106744. [PMID: 32623229 DOI: 10.1016/j.intimp.2020.106744] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Miao H, Chen D, Li R, Hu J, Chen Y, Xu C, Wen Z. Identification of an immune-related six-long noncoding RNA signature as a novel prognosis biomarker for adenocarcinoma of lung. Biosci Rep 2021;41:BSR20202444. [PMID: 33324975 DOI: 10.1042/BSR20202444] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
28 Campa MJ, Moody MA, Zhang R, Liao HX, Gottlin EB, Patz EF Jr. Interrogation of individual intratumoral B lymphocytes from lung cancer patients for molecular target discovery. Cancer Immunol Immunother 2016;65:171-80. [PMID: 26739486 DOI: 10.1007/s00262-015-1787-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
29 Malas S, Harrasser M, Lacy KE, Karagiannis SN. Antibody therapies for melanoma: new and emerging opportunities to activate immunity (Review). Oncol Rep 2014;32:875-86. [PMID: 24969320 DOI: 10.3892/or.2014.3275] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
30 Harris RJ, Cheung A, Ng JCF, Laddach R, Chenoweth AM, Crescioli S, Fittall M, Dominguez-Rodriguez D, Roberts J, Levi D, Liu F, Alberts E, Quist J, Santaolalla A, Pinder SE, Gillett C, Hammar N, Irshad S, Van Hemelrijck M, Dunn-Walters DK, Fraternali F, Spicer JF, Lacy KE, Tsoka S, Grigoriadis A, Tutt ANJ, Karagiannis SN. Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer. Cancer Res 2021;81:4290-304. [PMID: 34224371 DOI: 10.1158/0008-5472.CAN-20-3773] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Trimble CL. HPV Infection-Associated Cancers: Next-Generation Technology for Diagnosis and Treatment. Cancer Immunol Res 2014;2:937-42. [PMID: 25281321 DOI: 10.1158/2326-6066.CIR-14-0152] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
32 Nelson BH. New insights into tumor immunity revealed by the unique genetic and genomic aspects of ovarian cancer. Curr Opin Immunol 2015;33:93-100. [PMID: 25710852 DOI: 10.1016/j.coi.2015.02.004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
33 Suárez-Sánchez FJ, Lequerica-Fernández P, Rodrigo JP, Hermida-Prado F, Suárez-Canto J, Rodríguez-Santamarta T, Domínguez-Iglesias F, García-Pedrero JM, de Vicente JC. Tumor-Infiltrating CD20+ B Lymphocytes: Significance and Prognostic Implications in Oral Cancer Microenvironment. Cancers (Basel) 2021;13:395. [PMID: 33494389 DOI: 10.3390/cancers13030395] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
34 Wang SS, Liu W, Ly D, Xu H, Qu L, Zhang L. Tumor-infiltrating B cells: their role and application in anti-tumor immunity in lung cancer. Cell Mol Immunol 2019;16:6-18. [PMID: 29628498 DOI: 10.1038/s41423-018-0027-x] [Cited by in Crossref: 69] [Cited by in F6Publishing: 78] [Article Influence: 17.3] [Reference Citation Analysis]
35 Qin M, Hamanishi J, Ukita M, Yamanoi K, Takamatsu S, Abiko K, Murakami R, Miyamoto T, Suzuki H, Ueda A, Hosoe Y, Horie A, Yamaguchi K, Mandai M. Tertiary lymphoid structures are associated with favorable survival outcomes in patients with endometrial cancer. Cancer Immunol Immunother 2021. [PMID: 34689225 DOI: 10.1007/s00262-021-03093-1] [Reference Citation Analysis]